SCHEMBL4166867

SCHEMBL4166867

CCCCCCCCCCCCCCOC(=O)C(=O)CCC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.55
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
PTPN1 P18031 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52
ALOX15 P16050 1/20 0.52
PDE4A P27815 1/20 0.52
KMT2A Q03164 1/20 0.52
PDE3A Q14432 1/20 0.52
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4164193 1.00 TSHR (0.55) TSHRGPR84PPARGPPARDPPARA
SCHEMBL30254792 1.00 TSHR (0.55) TSHRGPR84PPARGPPARDPPARA
SCHEMBL4160109 1.00 TSHR (0.55) TSHRGPR84PPARGPPARDPPARA
SCHEMBL4157138 1.00 TSHR (0.55) TSHRGPR84PPARGPPARDPPARA
SCHEMBL18735392 0.92 ALDH1A1 (0.48) TSHRGPR84PPARGPPARDPPARA
SCHEMBL17980377 0.91 GPR84 (0.61) TSHRGPR84PPARGPPARDPPARA
SCHEMBL7752967 0.91 GPR84 (0.55) TSHRGPR84PPARGPPARDPPARA
SCHEMBL16044475 0.90 TSHR (0.59) TSHRALDH1A1NAAAFAAHHCAR2
SCHEMBL17980418 0.87 GPR84 (0.61) TSHRGPR84PPARGPPARDPPARA
SCHEMBL9002350 0.86 FAAH (0.61) TSHRNAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005437-A1 Alpha-Ketoglutarates and Their Use as Therapeutic Agents UNIVERSITY OF STRATHCLYDE (GB) 2009-01-01 US disclosed
EP-1778616-A1 ALPHA-KETOGLUTARATES AND THEIR USE AS THERAPEUTIC AGENTS Cancer Research Technology Limited (GB) 2007-05-02 EP disclosed
WO-2006016143-A1 ALPHA-KETOGLUTARATES AND THEIR USE AS THERAPEUTIC AGENTS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2006-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005437-A1 Alpha-Ketoglutarates and Their Use as Therapeutic Agents HIF1A, HIF1AN, EGLN3 TSHR 3662/4885GPR84 492/4885PPARG 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.